8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 20, 2016

 

 

DAVITA HEALTHCARE PARTNERS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-14106   No. 51-0354549

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

2000 16th Street

Denver, CO 80202

(Address of principal executive offices including Zip Code)

(303) 405-2100

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to Vote of Security Holders.

On June 20, 2016, the Company held its annual meeting of stockholders in Denver, Colorado. Represented in person or by proxy at the annual meeting were 173,243,708 shares of the Company’s common stock, or 83.88% of its outstanding shares of common stock. The results of matters submitted to a stockholder vote at the annual meeting are as follows:

Item 1. Election of Directors.

Ten board nominees for director were elected by a majority of the votes cast for a term of one year or until their successors are duly elected and qualified. The voting results are as follows:

 

Name of Nominee   For   Against   Abstain   Broker non-votes

Pamela M. Arway

  157,836,914   2,334,626   62,437   13,009,731

Charles G. Berg

  159,285,174   878,394   70,409   13,009,731

Carol Anthony (“John”) Davidson

  159,334,354   835,115   64,508   13,009,731

Barbara J. Desoer

  160,019,804   149,000   65,173   13,009,731

Paul J. Diaz

  157,520,465   2,650,699   62,813   13,009,731

Peter T. Grauer

  155,378,319   4,790,985   64,673   13,009,731

John M. Nehra

  157,772,868   2,395,885   65,224   13,009,731

William L. Roper

  158,311,566   1,856,413   65,998   13,009,731

Kent J. Thiry

  154,869,501   4,744,737   619,739   13,009,731

Roger J. Valine

  156,757,895   3,403,976   72,106   13,009,731

Item 2. Ratification of appointment of independent registered public accounting firm.

The stockholders ratified the appointment of KPMG LLP as our independent registered public accounting firm for 2016. The voting results are as follows:

 

For

  Against   Abstain
171,881,227   1,292,094   70,387

Item 3. Advisory vote on executive compensation.

The proposal received the vote of a majority of the shares represented and entitled to vote at the meeting. The voting results are as follows:

 

For

  Against   Abstain   Broker non-votes
137,966,037   22,007,013   260,927   13,009,731

Item 4. Amendments to Bylaws to adopt proxy access.

The proposal received the vote of a majority of the shares represented and entitled to vote at the meeting. The voting results are as follows:

 

For

  Against   Abstain   Broker non-votes
156,040,671   4,120,724   72,582   13,009,731

Item 5. Amendment to the Employee Stock Purchase Plan to increase the number of shares available by 7,500,000 shares.

The proposal received the vote of a majority of the shares represented and entitled to vote at the meeting. The voting results are as follows:

 

For

  Against   Abstain   Broker non-votes
158,429,002   1,191,839   613,136   13,009,731


Item 6. Stockholder proposal regarding action by written consent.

The proposal received the vote of less than a majority of the shares represented and entitled to vote at the meeting. The voting results are as follows:

 

For

  Against   Abstain   Broker non-votes
22,433,910   137,000,186   799,881   13,009,731


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    DAVITA HEALTHCARE PARTNERS INC.
Date: June 24, 2016     By:   /s/  Martha Ha      
      Martha Ha
      Corporate Secretary